The Journal of allergy and clinical immunology

The most recent articles from: J. Allergy Clin. Immunol. May 2019

J. Allergy Clin. Immunol. · May 2019

Randomized Controlled Trial Multicenter Study

Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma.

Mepolizumab has demonstrated favorable safety and efficacy profiles in placebo-controlled trials of 12 months' duration or less; however, long-term data are lacking. ⋯ These data support the long-term safety and efficacy of mepolizumab in patients with SEA.

read on… or not…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.